Is Pain Reprocessing Therapy Evidence-Based?

Okay, but does this actually work?

Fair question.

Pain Reprocessing Therapy asks people to consider something that can feel pretty radical at first: that pain they have been feeling in their body—sometimes for years—may not be a sign that their body is damaged.

Then it asks them to respond to that pain differently.

That is a lot to ask someone to take on faith.

Fortunately, you don’t have to.

I get the skepticism more than most. Before I ever learned about neuroplastic pain, I spent more than four years bouncing between doctors, specialists, diagnoses, treatments, medications, and more medical appointments than I care to count.

If someone had told me early on that my brain and nervous system could be creating or amplifying my symptoms, I’m honestly not sure how well I would have received it.

I wanted evidence.

I wanted something that made sense.

And I wanted to know that people weren’t just telling me to “think positive” about symptoms that were very, very real.

So when I eventually learned about Pain Reprocessing Therapy, the research mattered to me too.

The strongest research on PRT so far comes from a randomized clinical trial on chronic back pain, and the results were impressive enough that they’re a big part of why so many people are now talking about neuroplastic pain.

But I also want to be careful about what “evidence-based” means.

PRT has not yet been studied in large randomized trials for every possible neuroplastic symptom.

That does not mean we only have reason to think it applies to back pain.

PRT was developed to address centrally mediated or neuroplastic pain more broadly, and since the original back-pain trial, researchers have begun studying it in other conditions too. A 2025 pilot study in people with fibromyalgia found significant reductions in pain, pain interference, and pain-related fear after a brief three-session version of PRT. A 2025 case series also reported substantial improvements in three people with chronic migraine who had not responded adequately to standard treatments. Those are early studies, not the same level of evidence as a large randomized trial, but they matter.

And outside of research studies, PRT is now being used with people experiencing many different forms of neuroplastic pain and other symptoms.

That kind of real-world clinical experience is not the same thing as a controlled study.

But it isn’t nothing either.

So, let’s look at what we actually know.

The study that put PRT on the map

In a randomized clinical trial conducted in Boulder, Colorado, researchers recruited 151 adults who had experienced chronic back pain for an average of about 10 years.

These weren’t people with a brand-new backache.

They had been hurting for a long time.

The participants were randomly assigned to one of three groups: Pain Reprocessing Therapy, an open-label placebo treatment, or their usual care.

The people receiving PRT had one telehealth visit with a physician followed by eight treatment sessions over four weeks.

And then the researchers looked at what happened to their pain.

This is the part that caught people’s attention.

After four weeks, 66% of the people assigned to PRT were pain-free or nearly pain-free.

In comparison, that was true for 20% of the placebo group and 10% of the usual-care group.

That is a pretty striking difference.

Especially when you remember that, on average, these people had been experiencing back pain for a decade.

But did the pain just come back?

This is always one of my first questions when I see impressive results from a short treatment.

Okay. But what happened later?

The researchers wondered that too.

At the one-year follow-up, the PRT group was still reporting significantly less pain than either the placebo or usual-care groups. The gains had largely been maintained.

And then, years later, the researchers went back again.

A five-year follow-up was published in JAMA Psychiatry in 2025. Of the original 151 participants, 113 took part in that follow-up.

At five years, the people who had received PRT were still reporting significantly lower pain than those who had received placebo or usual care.

Fifty-five percent of the PRT participants who completed the five-year follow-up reported being nearly or completely pain-free, compared with 26% of the placebo group and 36% of the usual-care group.

Five years.

I think that’s important.

PRT isn’t meant to teach someone how to grit their teeth and live with pain a little better.

The goal is to help the brain actually change the way it is interpreting and responding to signals from the body.

The fact that those differences were still present years later suggests that something about that learning lasted.

What were they actually doing in PRT?

This is where the research gets even more interesting to me.

The treatment wasn’t about convincing people that their pain didn’t exist.

It wasn’t positive thinking.

And nobody was sitting across from them saying:

Your back is fine. Stop worrying about it.

The researchers described PRT as helping participants reconceptualize their pain as coming from nondangerous brain activity rather than ongoing tissue injury, using cognitive, somatic, and exposure-based techniques.

In normal-person language:

They were helping the brain learn that the pain did not mean danger.

If you’ve read my article on What Is Pain Reprocessing Therapy?, you’ve heard me talk about the pain-fear cycle.

Pain happens.

Uh oh. What’s wrong?

Fear goes up.

We monitor.

We brace.

We avoid.

We Google.

We become very, very aware of what our back is doing.

And all of that can give the brain even more reason to believe something dangerous is happening.

PRT works on changing that relationship.

Not: I don’t feel this.

But: I feel this, and I don’t believe it means I’m hurting myself.

Those are two very different things.

Did researchers see changes in the brain?

They did.

Some of the participants underwent functional MRI scans before and after treatment.

Researchers found changes in brain responses and connectivity in regions involved in pain processing in the PRT group compared with the control groups.

I want to be a little cautious with this part, because brain scans make everything sound wonderfully definitive.

Look! There it is! Proof!

Science is rarely that tidy.

The study authors noted that the imaging effects were modest and that some findings did not survive more stringent whole-brain statistical correction.

So I wouldn’t point to an fMRI image and say:

See? We can watch PRT cure pain in the brain.

But the imaging findings do add another interesting piece to the puzzle alongside what participants were actually reporting about their pain.

What about symptoms other than back pain?

This is where I think the conversation gets more interesting than it was even a few years ago.

The original randomized trial was specifically conducted in people with primary chronic back pain.

So no, we cannot take that 66% number and apply it to migraines, fibromyalgia, pelvic pain, IBS, fatigue, dizziness, or every other symptom that may have a neuroplastic component.

That would be overstating the research.

But it would also be misleading to imply that the story ends with back pain.

Researchers are beginning to study PRT in other conditions.

In a 2025 pilot study of 35 adults with fibromyalgia, participants received three telehealth PRT sessions. Among those who completed treatment, researchers found significant reductions in pain intensity, pain interference, and pain-related fear over the following three months. At three months, 42% reported being “much improved” or “very much improved.”

That study did not include a control group, so it cannot prove that PRT caused those improvements.

But the results were promising enough that the authors called for larger randomized trials.

There is also now published work looking at PRT for chronic migraine.

In a small 2025 case series, three people with chronic migraine who had not responded adequately to standard treatments all experienced large reductions in headache frequency after PRT. The researchers were careful to describe this as preliminary evidence and called for controlled trials.

So the research is expanding.

And then there is something research papers have a harder time capturing:

What happens in real life.

PRT practitioners and other mind-body practitioners are working every day with people experiencing back pain, migraines, fibromyalgia, pelvic pain, digestive symptoms, dizziness, fatigue, and many other symptoms that may involve nervous-system sensitization.

People do get better.

I’ve watched it happen.

I’ve experienced it myself.

So, is Pain Reprocessing Therapy evidence-based?

To me, the most accurate answer is:

Yes, PRT has meaningful research behind it. And that research is still growing.

We have a randomized controlled trial showing substantial and durable reductions in primary chronic back pain, with differences still present five years later.

We now also have early published research in fibromyalgia and chronic migraine.

And we have a growing body of pain science showing us that pain is influenced by far more than the physical condition of the body alone.

Does that mean every person who tries PRT will recover?

Of course not.

No treatment works for every person.

But I also don’t think the takeaway from this research should be:

Well, technically we need more studies.

We do.

Science should keep studying this.

But the takeaway can also be:

The brain and nervous system are capable of producing persistent pain—and they are capable of changing.

For someone who has spent years believing that their body is permanently damaged, that is not a small thing.

It is hope.

And in this work, hope matters.

Wondering whether PRT could apply to your symptoms?

If you’re wondering whether your own symptoms might have a neuroplastic component, you can start with my free Neuroplastic Symptoms Self-Assessment or read How Do I Know If My Symptoms Are Neuroplastic?

And if you’d rather talk it through with a real person, I offer free 15-minute connect calls where we can talk a little about what you’ve been experiencing, what you’ve already tried, and whether PRT might make sense as something to explore.

We have a growing understanding of how fear, threat interpretation, attention, learning, and nervous-system sensitization can influence the experience of pain.

And we have countless real-world examples of people learning that their bodies were safer than they thought—and watching their symptoms change as that belief changed.

The brain and nervous system are capable of producing persistent pain—and they are capable of changing.

For someone who has spent years believing that their body is permanently damaged, that is not a small thing.

It is hope.

And in this work, hope matters.